Relatlimab
Relatlimab (BMS-986016) is a monoclonal antibody targeting human anti-LAG-3, generated by immunization of transgenic mice with human immunoglobulin carrying recombinant LAG-3 protein.Relatlimab has a blocking effect, blocking the interaction of LAG-3/MHC II (IC50: 0.67 nM) and LAG-3/FGL1 (IC50: 0.019 nM) . Relatlimab is often used with Nivoluma to treat advanced melanoma.
Product Specifications
CAS Number
1673516-98-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS640947-01 5 Slides
Tissue, Section, Human Disease, Progressive Supranuclear Palsy, Brain, Parietal Lobe (Frozen)
Sign In for Pricing
View Details MBS640947-02 5x 5 Slides
Tissue, Section, Human Disease, Progressive Supranuclear Palsy, Brain, Parietal Lobe (Frozen)
Sign In for Pricing
View Details 
bs-41199R-BF555 100 µL
Laminin alpha 1 Polyclonal Antibody, AbBy Fluor™ 555 Conjugated
Sign In for Pricing
View Details MBS6443757-01 0.1 mL
ZDHHC17 (Zinc Finger CCHC Domain Containing 17, HIP3, HYPH, HIP14, HSPC294) (Biotin)
Sign In for Pricing
View Details